Parallax Volatility Advisers, L.P. Catalyst Biosciences, Inc. Transaction History

Parallax Volatility Advisers, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.33 - $0.65 $5,131 - $10,106	-15,549 Reduced 26.2%	43,804 $21,000
Q2 2023 Aug 14, 2023	SELL	$0.2 - $0.35 $3,851 - $6,740	-19,259 Reduced 24.5%	59,353 $20,000
Q1 2023 May 15, 2023	BUY	$0.19 - $0.64 $11,668 - $39,303	61,411 Added 357.02%	78,612 $16,000
Q4 2022 Feb 14, 2023	BUY	$0.49 - $0.57 $8,428 - $9,804	17,201 New	17,201 $9,000
Q4 2020 Feb 16, 2021	BUY	$4.55 - $7.29 $326,189 - $522,620	71,690 New	71,690 $452,000
Q4 2018 Feb 14, 2019	SELL	$6.59 - $11.28 $44,805 - $76,692	-6,799 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$9.35 - $12.44 $63,570 - $84,579	6,799 New	6,799 $73,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.